Endothelial cell-selective adhesion molecule (ESAM) is a new member of the immunoglobulin superfamily, which is expressed in vascular endothelial cells. Previous studies have demonstrated that ESAM regulates angiogenesis, endothelial permeability, and leukocyte transmigration. However, little is known concerning the role of ESAM in atherosclerosis.
Introduction
Atherosclerosis is a complex process characterized by accumulation of lipids and fibrous elements in the large arteries. The vascular endothelium is known to protect the vessel wall against the development of atherosclerosis because it inhibits adhesion of circulating inflammatory cells to the vessel wall, vascular smooth muscle cell migration and proliferation, and thrombus formation. Endothelial dysfunction therefore directly contributes to the initiation and progression of atherosclerosis. (Price and Loscalzo, 1999; Sprague and Khalil, 2009; Springer, 1990; Taddei et al., 2003) Infiltration of inflammatory cells into the vessel wall is a crucial step in the development of atherosclerosis, especially since the early lesions of atherosclerosis involve the accumulation of cholesterol-engorged macrophages. The vascular endothelium thus plays a pivotal role in the process of atherosclerosis including macrophage recruitment. (Ley et al., 2007) Endothelial cells feature several adhesion molecules at the cell surface such as vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), and platelet selectin (P-selectin). (Cybulsky et al., 2001) These molecules are upregulated by atherogenic stimuli and thereby contribute to the adhesion and infiltration of macrophages. In this context, atherosclerosis is considered as an inflammatory disease. (Ross, 1999) In addition, it has been postulated that progression of atherosclerosis depends on new blood vessel formation, which is referred to as vasa vasorum, in the vessel wall. The function of vasa vasorum is to deliver nutrients and oxygen to vessel walls and to remove waste products, either produced by cells in the wall or introduced by diffusional transport through the endothelium. (Bolla et al., 1999; Ritman and Lerman, 2007) Previous studies have demonstrated that increases in the volume of vasa vasorum match those in the needs of the growing vessel wall. (Moulton et al., 2003) In fact, inhibition of microangiogenesis by angiostatin can interrupt the secondary reduction of macrophage accumulation, which established that vasa vasorum could be the source of the inflammatory cells. (Moulton et al., 2003) In addition, recombinant plasminogen activator inhibitor (rPAI-1 23 ), which has significant antiangiogenic activity, inhibits growth of vasa vasorum as well as vessels within the adjacent plaque and vessel wall through inhibition of fibroblast growth factor-2, which in turn leads to a reduction in plaque growth in atherogenic mouse. (Drinane et al., 2009 ) From these findings, it is reasonable to hypothesize that vasa vasorum may contribute to the formation of atherosclerosis through modulating infiltration of inflammatory cells and blood vessel formation in the plaque.
The endothelial cell-selective adhesion molecule (ESAM) is a new member of the immunoglobulin superfamily, which is highly expressed by vascular endothelial cells. (Hirata et al., 2001; Nasdala et al., 2002) ESAM has been shown to mediate homophilic and calcium-independent adhesion of endothelial cells. (Hirata et al., 2001) Previous studies have demonstrated that ESAM regulates tumor angiogenesis, vascular permeability, and leukocyte transmigration both in vitro and in vivo. (Hara et al., 2009; Ishida et al., 2003; Wegmann et al., 2006) While these lines of evidence suggest that ESAM may play a pivotal role in the genesis of atherosclerosis, the role of ESAM in atherogenesis has not been reported. The apolipoprotein E-deficient (apoE-/-) mice has been extensively characterized in terms of the altered lipoprotein profiles and predisposition to atherosclerosis. ApoE-/-mice have markedly elevated serum cholesterol associated with increased VLDL/LDL-cholesterol and reduced HDL-cholesterol. As a result of this highly atherogenic lipoprotein profile, apoE-/mice spontaneously develop complex atherosclerotic lesions. The aim of the study reported 5 here, was therefore to explore the role of ESAM in the murine model of atherosclerosis using ESAM-deficient (ESAM-/-) mice. To initiate studies investigating ESAM involvement in atherosclerosis, ESAM-/-mice with a C57Bl/6 background were bred with apoE-/-mice with a C57Bl/6 background. We tested how targeted inactivation of ESAM modulates formation and progression of the atherosclerotic plaque in apoE-/-mice through plaque angiogenesis and leukocyte-endothelium interaction.
Materials and Methods

Animal preparation
Homozygous apoE-/-mice with C57BL/6J background were obtained from the Jackson Laboratory (Bar Harbor, ME), and bred with ESAM-/-mice with a C57BL/6J background (Ishida et al., 2003) to generate ESAM-/-apoE-/-double knockout mice. Genotyping of the apoE locus was performed as described elsewhere. (Bolla et al., 1999) Genotyping of the ESAM locus was performed by means of polymerase chain reaction (PCR) using the following primers: 5'-ggcagctagaacactcttggggagg-3' (forward primer corresponding to the first intron in the ESAM genomic sequence), 5'-ggggagacttagaaccctaccgagc-3' (reverse primer corresponding to the first intron in ESAM), 5'-gtggatgtggaatgtgtgcgaggcc-3' (forward primer corresponding to the PGK promoter in the pKO Scrambler NTKV1901 targeting vector). The PCR was performed with 40 cycles at 93 ºC for 1 min, 54 ºC for 2 min, and 72 ºC for 2 min, and yielded a 330-bp in single band ESAM-/-mice, a 392-bp single band in ESAM+/+ mice, and 330-and 392-bp double bands in ESAM+/-mice. ApoE-/-and ESAM-/-apoE-/-mice were weaned at 4 weeks of age and maintained on a normal chow diet (Oriental Yeast, Inc., Tokyo, Japan) for 12 weeks. Between 14 and 16 mice were included in each experimental subgroup. All animal 6 experiments were conducted according to the Guidelines for Animal Experiments of Kobe University Graduate School of Medicine and the Guide for the Care and Use of Laboratory Animals published by the National Institute of Health (NIH Publication No. 85-26, revised 1996) .
Analysis of plasma lipids
Following an overnight fast, whole blood was collected by cardiac puncture into tubes containing 0.3 mg EDTA. Plasma was obtained by centrifugation at 8000 x g for 5 min at 4 °C. Plasma levels of total cholesterol (T-cho), high-density lipoprotein cholesterol (HDL-C), and triglyceride were measured with biochemial assays at Oriental Yeast, Inc.
Histological analysis of atherosclerotic lesions
The apoE-/-and ESAM-/-apoE-/-mice were euthanized at the age of 16 or 20 weeks (12 or 16 weeks on the chow diet), and the atherosclerotic lesions were analyzed as described previously. (Ishida et al., 2003; Ozaki et al., 2002; Pan et al., 2004; Sun et al., 2009 En face analysis of the aortic lesion was performed as described previously. (Drinane et al., 2009; Ozaki et al., 2002) The distal part of the excised aorta (from aortic arch to iliac bifurcation) was dissected free from surrounding tissues, opened longitudinally, and pinned onto a silicon-coated dish. Oil-red-O stained aortas were subjected to image analysis with the ImageJ software.
Immunohistochemistry
Aortic sections of 8-12 µm were cut on a freezing microtome, and mounted on slides. After reduction of endogenous peroxidase activity with 0.1% hydrogen peroxide for 15 minutes at room temperature, nonspecific binding was blocked with 2% bovine serum albumin in PBS for 30 minutes. The tissue sections were then incubated for 24h with an anti-mouse monocyte/macrophage antibody (MOMA-2; Biosource International, Camarillo, CA) diluted in PBS, followed by incubation with N-Histofine ® Simple Stain Mouse MAX PO (Nichirei Bioscience, Tokyo, Japan). For fluorescent analysis of vascular structures, aortic sections were incubated with Alexa Fluor568-conjugated anti-isolectin antibody (Invitrogen) or an FITC-conjugated anti-smooth muscle -actin antibody (-SMA; Sigma-Aldrich, St. Louis, MO). Samples were observed with the Biozero BZ-8000 fluorescent microscope (Keyence, Osaka, Japan).
Whole-mount analysis of vasa vasorum in the aorta was performed as previously described. (Drinane et al., 2009 ) Descending aortas were collected with a wide margin and made permeable in an overnight incubation at 4 ºC in PBS containing 0.5% Triton-X. The aortas were then incubated overnight at 4 ºC with 5 g/mL Alexa Fluor568-conjugated anti-isolectin antibody in Can Get Signal immunostain solution. Isolectin-probed adventitial 8 vessels were imaged on a Zeiss LSM-510 META point scanning confocal microscope (Carl Zeiss Vision GmbH, Hallbergmoos, Germany),followed by the collection of Z stacks.
Cell culture, transfection, and siRNA experiment
Human umbilical vein endothelial cells (HUVEC), human aortic endothelial cells (HAEC), J774.1 cells (a murine monocyte cell line), and THP-1 (a human monocyte/macrophage cell line) were purchased from American Type Culture Collection (Manassas, VA). HUVEC at passages 4-10 was cultured on gelatin-coated culture plates according to the manufacturer's recommendations. The siRNA-mediated knockdown of ESAM was performed using a siGENOME SMARTpool specific for human ESAM (Dharmacon, Lafayette, CO). The confluent monolayer of HUVEC was transfected with the ESAM siRNA or Stealth RNAi negative control and using the Lipofectamine RNAiMAX reagent (Invitrogen). (Hara et al., 2009 ) After incubation for 24-48 hours, in vitro transmigration assays were performed using the ESAM-depleted HUVEC and THP-1 cells. In a subset of knockdown of adhesion molecules on macrophages, THP-1 cells were transfected with siRNA for LFA-1, VLA-4, Mac1, JAM1, CD99, or Stealth RNAi negative control (Thermo Fisher Scientific, Waltham, MA) for in vitro adhesion assays.
In vitro adhesion assay
The recombinant soluble form of ESAM was made as a fusion protein with the extracellular domain of ESAM and maltose-binding protein (MBP) and using the pMAL Protein Fusion and
Purification System (New England Biolabs, Ipswich, MA). The cDNA for the extracellular domain of murine ESAM was obtained by PCR using the primers 5-tcagaattcatgattcttcaggctggaacccccgagacc-3' and 5-gactctagaggaccctgtcatcacgtccaaggtcacgtt-3', and cloned into the pMAL-C2X vector in the same translational reading frame as the malE gene encoding MBP. The fusion protein of the truncated ESAM and MBP (ESAM-MBP) was thus produced by using DH5 competent cells, and purified by means of amylose affinity chromatography according to the manufacturer's instruction. Adhesion assays using the truncated ESAM protein were performed as described previously. (Frankel et al., 1994) Briefly, culture dishes were coated with 2-10 µg of ESAM-MBP fusion protein or MBP (control). Monocyte/macrophage cell line THP-1, or J774.1 cells were labeled with 1 µmol/L calcein-AM (Molecular Probes, Eugene, OR), added onto the ESAM-MBP-coated dish, and incubated at 37 for 40 minutes. After washing 3 times, the number of adherent THP-1 cells or J774.1 cells was counted under a fluorescent microscopy.
In vitro transmigration assay
The in vitro transmigration assay was performed as described previously. (Faure et al., 2006; Liu et al., 2008) HUVEC or HAEC were grown to confluency in a 24-well culture insert (3-µm pore size Transwell; Corning, Tokyo, Japan) in 200 µL RPMI containing 10% fetal calf serum and 30 µg/mL endothelial cell growth supplements. After transfection of ESAM siRNA or non-target siRNA, 2.0 x 10 4 THP-1 cells in RPMI containing 0.2% fetal calf serum were added to the upper chamber. In the lower chamber, 500 µL RPMI containing 10 ng/mL monocyte chemoatrractant protein-1 (MCP-1, PeproTech, Rocky Hill, NJ) was placed to stimulate cell migration. Cells in the upper chamber were removed after 90 or 180 minutes, while transmigrated THP-1 cells in the lower chamber were labeled with calcein-AM and counted under a fluorescent microscope.
Chemically induced peritonitis model
Thioglycollate-induced peritonitis was generated as described previously. (Bixel et al., 2007) Female ESAM-/-and ESAM+/+ mice, 10-14 weeks old, were used for this assay.
Thioglycollate medium (4%) was injected into the peritoneal cavity to evoke macrophage-dominant inflammation. Four days later, the mice were sacrificed, and peritoneal lavage was performed with 10 mL of PBS. The total number of cells in the peritoneal fluid was determined with a cell counter.
Statistical analysis
Data were expressed as mean±SE. An unpaired Student t test was used to detect significant differences when two groups were compared. One-way ANOVA was used to compare the differences among three or four groups, followed by Bonferroni's test for post hoc analysis. P values less than 0.05 were considered statistically significant.
Results
Atherosclerosis is attenuated in mice with functional ESAM deletion
Male and female apoE-/-and ESAM-/-apoE-/-mice were evaluated for development of atherosclerosis. After 12 weeks on normal chow, when the mice were 16 weeks old, atherosclerotic lesion formation was evaluated by means of oil-red-O staining of sections at the aortic valve level (Fig. 1A) . Extent of disease was quantified as total lesion area determined planimetrically. Interestingly, the atherosclerotic lesions were markedly attenuated in double knockout mice compared with in apoE-/-mice: a significant decrease by 41% in males (p<0.005) and by 24% in females (p<0.05) (Fig. 1C ). The aorta en face analysis by means of oil-red-O staining at the age of 16 weeks confirmed that plaque areas had decreased by 41% in ESAM-/-apoE-/-mice compared to in apoE-/-mice ( Fig. 1B and 1D) . Therefore, targeted inactivation of ESAM in apoE-/-mice results in a marked reduction of the size of the atherosclerotic lesion.
Plasma lipid profiles do not explain attenuated atherosclerosis in ESAM-/-mice
To investigate the mechanism by which atherosclerosis was attenuated in the double knockout animals, lipid profiles were obtained from control ESAM+/+, single knockout apoE-/-, ESAM-/-, and double knockout ESAM-/-apoE-/-male and female mice on normal chow diets.
There were significant differences in lipid profiles among the mouse groups (Table 1) . Male and female ESAM-/-mice showed modestly higher T-cho and triglyceride levels than ESAM+/+ mice did, whereas HDL-C levels were not statistically different between the two groups. As for apoE-/-animals, male and female ESAM-/-apoE-/-mice showed markedly higher T-cho, HDL-C, and triglyceride levels than did apoE-/-mice. As a result, there were no significant differences in T-cho/HDL ratio between ESAM-/-apoE-/-and apoE-/-mice (Table 1) . Thus, although ESAM deficiency resulted in an increase in plasma levels both of atherogenic and antiatherogenic lipoproteins in apoE-/-animals, the plasma lipid profiles did not explain the attenuated atherosclerosis in ESAM-/-apoE-/-mice.
ESAM expression in the vascular wall may correlate with plaque neovascularization
Since the lipoprotein profile in ESAM-/-apoE-/-animals did not provide a clear indication of the mechanism for the decrease observed in atherosclerosis, we investigated differences in the vascular wall of the apoE-/-single and ESAM-/-apoE-/-double knockout mice. Because ESAM deficiency has been shown to reduce pathological angiogenesis in mice, we assessed neovascularization (vasa vasorum) around the atheroma in each section. The total number of blood vessels in the adventitia was less in ESAM-/-mice than in WT mice ( Fig. 2A vs. 2D, and   2G ). Similarly, the total number of blood vessels was less in ESAM-/-apoE-/-mice than in apoE-/-mice ( Fig. 2B vs. 2E, and 2G) . When we compared the number of vessels by size, small vessels in particular, those under 50 µm in diameter, were markedly reduced in ESAM-/-apoE-/-mice ( Fig. 2H) , supporting the notion of attenuated neovascularization resulting from ESAM deficiency. A whole-mount immunofluorescein study using fluorescein-conjugated isolectin revealed that formation of vasa vasorum in ESAM-/-apoE-/mice was significantly attenuated compared with that in apoE-/-mice ( Fig. 2C vs. 2F, and 2I) .
These findings indicate that ESAM deficiency results in a reduction in plaque angiogenesis around the atheroma.
ESAM regulates monocyte infiltration and complexity of atherosclerotic lesions
To further examine whether lesions in the apoE-/-and ESAM-/-apoE-/-mice had different cellular composition, we analyzed the atherosclerotic areas by histological and immunohistochemical stainings of with antibodies chosen to specifically label different cell types. Masson's Trichrome and Elastica van Gieson stainings revealed higher elastic fiber and lower collagen fiber contents in the plaque lesion in ESAM-/-apoE-/-than in apoE-/-mice ( Fig. 3A) . Next, an antibody to MOMA-2 was employed to evaluate the area containing infiltrating macrophages (Figs. 3A and 3B) . The percentage of MOMA-2-stained areas in the 13 aortic sinus lesions was significantly smaller in ESAM-/-apoE-/-mice, which is consistent with the overall smaller number of macrophages in these lesions (Fig. 3B ). There were no significant differences in the T-cell or smooth muscle cell compositions of the lesions in the apoE-/-and the ESAM-/-apoE-/-mice as demonstrated immunohistochemically with antibodies to CD3 or smooth muscle -actin, respectively (data not shown). Therefore, ESAM deficiency appeared to reduce not only the size and macrophage content but also the complexity of the atherosclerotic lesions.
To clarify whether the reduced macrophage recruitment is reproducible, we used another model of the in vivo transmigration assay. Chemically induced peritonitis is a well-characterized model for macrophage recruitment in sites of acute inflammation in vivo.
The assay using this model showed that the number of transmigrated macrophages in the peritoneal cavity was significantly lower in ESAM-/-than in ESAM+/+ mice ( Fig. 3C ), suggesting ESAM may contribute to the recruitment of macrophages while inflammatory cells go through the endothelial cells.
Knockdown of ESAM in endothelial cells reduced transmigration of monocytes
To investigate the mechanism underlying the reduced macrophage content by ESAM deficiency, the in vitro transmigration assay was performed using an ESAM-depleted endothelial monolayer and THP-1 cells. When ESAM was downregulated in the monolayer of HUVEC, the transmigration of THP-1 cells was significantly attenuated compared to control siRNA treatment with 90-minute incubation. However, when a longer incubation of over 180 minutes was used, there was no significant difference between the two groups (Fig. 4A) .
Similar results were obtained in case with HAEC (Fig. 4B) . These findings indicate that 14 ESAM may regulate adhesion of macrophage to the endothelium and early-phase macrophage infiltration into the vascular tissue.
Furthermore, we documented a direct interaction between ESAM and THP-1 cells by means of the adhesion assay using truncated ESAM-MBP or MBP only (Fig. 5 ). As shown in Fig. 5B , coating of the culture plate with ESAM-MBP enhanced the adhesion of THP-1 in an ESAM dose-dependent manner compared to adhesion after the control MBP treatment. We confirmed similar results by adhesion assays using mouse monocyte/macrophage cell line J774.1 (data not shown). Thus, these findings support the notion of a measurable decrease in the macrophage composition of ESAM-negative lesions, and indicate a possible mechanism by which ESAM may have a direct impact on the development of vascular wall disease.
VLA-4, LFA-1, JAM1, MAC-1, or CD99 did not interact with ESAM
Because ESAM was not expressed by macrophages, (Hirata et al., 2001) we examined the validity of the hypothesis that a heterophilic ligand of ESAM is present on the macrophages, which regulates the interaction between monocytes and endothelial cells. Using siRNA techniques, we suppressed the expression of well-known adhesion receptors on macrophages, and followed this with in vitro adhesion assays.
As shown in Fig. 6 , downregulation of VLA-4, LFA-1, JAM1, Mac1, or CD99 in THP-1 did not affect the adhesion of THP-1 cells to the ESAM-MBP-coated plates. This indicates that ESAM probably interacts with unidentified ligand(s) other than these molecules on THP-1 cells.
Discussion
The study presented here demonstrated that targeted inactivation of ESAM in apoE-/-mice 15 resulted in a robust decrease in the size and complexity of atherosclerotic lesions in the aorta.
However, ESAM-/-apoE-/-mice showed higher plasma levels both of atherogenic and antiatherogenic lipoproteins than control apoE-/-mice, while the T-chol/HDL ratio was similar between apoE-/-and ESAM-/-apoE-/-mice. Although the reason for this difference in lipid profiles remains unclear, a plausible explanation for the lipid profile would be the delayed clearance of plasma lipoproteins as a result of ESAM deletion. ESAM is expressed in sinusoidal endothelial cells in the liver. (Jamieson et al., 2007) It has been reported that degeneration of sinusoidal fenestration under pathological conditions or with aging inhibits the uptake of lipoproteins by hepatocytes, which can be a cause of hyperlipidemia (DG et al., 2007; Khandoga et al., 2009) . In this connection, we recently documented a significant role for ESAM in the maintenance of endothelial fenestration, in that ESAM deletion was found to reduce the fenestration of endothelial cells in the glomeruli. (Hara et al., 2009) We therefore speculate that ESAM deletion may retard the clearance of plasma atherogenic lipoproteins through causing disorganization of sinusoidal endothelial fenestration. Further studies are required, however, to elucidate the effect of ESAM deficiency on plasma lipid profile.
Although changes in plasma lipid profiles are not sufficient to explain the attenuation of atherosclerosis in ESAM-/-apoE-/-mice, we found that ESAM deletion markedly reduced the number and vasa vasorum in the adventitia. A number of studies have suggested that the development of vasa vasorum is associated with that of atherosclerotic lesions in humans and hypercholesterolemic animal models. (Langheinrich et al., 2006; Moulton et al., 2003; Virmani et al., 2000; Williams et al., 1988) We previously reported that targeted inactivation of ESAM attenuates tumor angiogenesis, (Ishida et al., 2003) which was primarily attributable to a reduction in endothelial migration and tube formation. It is therefore reasonable to speculate 16 that the impairment of new blood vessel formation in the adventitia resulted in the reduction of the atherosclerotic lesion size in ESAM-/-mice. We confirmed that expression of the most potent angiogenic factor VEGF and its receptor VEGF-R2 were not decreased by ESAM deficiency (data not shown). Thus, the loss of ESAM is likely to have directly inhibited angiogenesis in our mode. The impairment of plaque angiogenesis may then have prevented the vascular tissue both from absorbing the nutrient and oxygen supply and from inhibiting the access of inflammatory cells to the plaque.
ESAM has been shown to perform important functions in neutrophil transmigration, although the mechanisms of these functions are not yet fully understood. Wegmann and colleagues have demonstrated that ESAM is involved in the extravasation of leukocytes at an early stage of the inflammatory process, although ESAM does not bind to neutrophils directly. (Wegmann et al., 2006) In addition, they showed that a lack of ESAM upregulates the expression of vascular endothelial growth factor (VEGF) and increases endothelial permeability. Hara and colleagues have reported that the tight junction in ESAM-/-mice was morphologically wide and irregular compared to that in ESAM+/+ mice, which resulted in an increase in permeability. (Hara et al., 2009 ) It is therefore thought that these changes in endothelial permeability may affect the process of monocyte infiltration. On the other hand, our study has shown for the first time that monocyte/macrophage cell line THP-1 or J774.1 cells directly bind to recombinant the ESAM protein, possibly through interaction with putative heterophilic ligand(s) on the cell. Thus, it is likely that ESAM may be involved in the adhesion and transmigration of circulating monocytes within the vessel wall, and subsequently promote macrophage infiltration into the plaque. Protein-protein interactions between hematopoietic and endothelial cells have been shown to regulate leukocyte recruitment in tissue. For example, integrin interactions with the immunoglobulin superfamily, which includes JAM-1 as a ligand of LFA-1, contribute to LFA-1 dependent transendothelial migration of T cells and neutrophils as well as LFA-1-mediated arrest of T cells. (Ostermann et al., 2002) In addition, Mac-1 with ICAM-1, VLA-4 with VCAM-1, and  V ß 3 with platelet-endothelial cell adhesion molecule all mediate the transmigration or adhesion of leukocytes. (Diamond et al., 1991; Elices et al., 1990; Piali et al., 1995) The number of adherent THP-1 cells was then counted and showed that knockdown of VLA-4, JAM-1, MAC-1, LFA-1, or CD99 in THP-1 cells did not significantly affect adhesion to ESAM-MBP-coated plates. 
